Carregant...

The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy

The role of the tumor suppressor mothers against decapentaplegic homolog 4 (SMAD4) has not yet been defined in patients (pts) with advanced pancreatic cancer (aPC). This translational research study was designed to evaluate the impact of tumoral SMAD4 loss on clinicopathological parameters and outco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Ormanns, Steffen, Haas, Michael, Remold, Anna, Kruger, Stephan, Holdenrieder, Stefan, Kirchner, Thomas, Heinemann, Volker, Boeck, Stefan
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455003/
https://ncbi.nlm.nih.gov/pubmed/28534865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18051094
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!